Product Information
RIVASTIGMINE 3 MG CAPSULE is a generic product labeled by Sun Pharmaceutical Industries Inc., priced at $0.1676 per EA under NDC 62756014686. Its NADAC has been published 639 times since Nov 28, 2013.
FDA first approved this application on Oct 22, 2007.
The High Outlier badge above means this manufacturer's average price in the Rivastigmine Tartrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
3 mg/1
Manufacturer
Sun Pharmaceutical Industries Inc.NDC
62756014686
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
2/18/2026
Active Ingredients
RIVASTIGMINE TARTRATEApproval Type
Generic (ANDA)
FDA Application
ANDA077131FDA Approved
10/22/2007
On Market Since
7/1/2010
Pharmacological Classes
Price Statistics
The NADAC for RIVASTIGMINE 3 MG CAPSULE has been published 639 times since Nov 28, 2013, and over the history we have for it it has declined 90.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1676 per EA |
|---|---|
| All-time high | $1.8210 (Feb 12, 2014) |
| All-time low | $0.1451 (Jul 17, 2024) |
| 52-week high | $0.2016 |
| 52-week low | $0.1676 |
| Median price | $0.3433 |
| Average price | $0.6412 |
| Largest weekly change | -37.0% (Sep 20, 2017) |
| Weeks tracked | 639 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-16.9%
3Y
-15.3%
5Y
-46.7%
All
-90.7%
Last surveyed Feb 18, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 11% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of RIVASTIGMINE 3 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for RIVASTIGMINE 3 MG CAPSULE, manufactured by Sun Pharmaceutical Industries Inc., is $0.1676 per EA (NDC 62756014686), effective Feb 18, 2026.
How has the price of RIVASTIGMINE 3 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for RIVASTIGMINE 3 MG CAPSULE has declined 90.7%. It has been tracked across 639 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for RIVASTIGMINE 3 MG CAPSULE?
Since Nov 28, 2013, the NADAC for RIVASTIGMINE 3 MG CAPSULE has ranged from a low of $0.1451 (Jul 17, 2024) to a high of $1.8210 (Feb 12, 2014), with a median of $0.3433 per EA.
Are there cheaper alternatives to RIVASTIGMINE 3 MG CAPSULE?
Yes. 6 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIVASTIGMINE 3 MG CAPSULE, is $0.1494 per EA — about 11% below RIVASTIGMINE 3 MG CAPSULE.
Who manufactures RIVASTIGMINE 3 MG CAPSULE?
RIVASTIGMINE 3 MG CAPSULE (NDC 62756014686) is labeled by Sun Pharmaceutical Industries Inc., and CMS classifies it as a generic product.